(Q34108996)

31 July 2017

title

Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia (English)

1 reference

31 July 2017

Phillip Scheinberg

1

1 reference

31 July 2017

Colin O Wu

series ordinal

2

1 reference

31 July 2017

Olga Nunez

series ordinal

3

1 reference

31 July 2017

Neal S Young

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

19 November 2008

1 reference

British Journal of Haematology

31 July 2017

published in

1 reference

31 July 2017

volume

144

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

206-216

1 reference

Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Telomere maintenance and human bone marrow failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Current concepts in the pathophysiology and treatment of aplastic anemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Prognosis in acquired aplastic anemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Androstane Therapy of Aplastic Anaemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Drug-induced aplastic anemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Aplastic anaemia. Histological investigation of methacrylate embedded bone marrow biopsy specimens; correlation with survival after conventional treatment in 15 adult patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Acquired aplastic anaemia in adults. I. A retrospective analysis of 40 cases: single factors influencing the prognosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Prognostic factors in aplastic anaemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Treatment of severe aplastic anemia with antilymphocyte globulin and androgens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Identification of high-risk patients with aplastic anaemia in selection for allogeneic 0one-marrow transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

The mortality of acquired aplastic anemia in children

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149225

Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapiant

28 October 2018

1 reference

12 December 2020

Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia

1 reference

12 December 2020

Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia

1 reference

12 December 2020

Treatment of aplastic anemia with anabolic steroids and corticosteroids

1 reference

12 December 2020

Anabolic androgenic steroids in the treatment of acquired aplastic anemia

1 reference

12 December 2020

Treatment and prognosis in aplastic anaemia

1 reference

12 December 2020

Selection of patients for bone marrow transplantation in severe aplastic anemia

1 reference

12 December 2020

Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality

1 reference

12 December 2020

Prognostic factors in acquired aplastic anemia. A study of 352 cases

1 reference

12 December 2020

Prognosis in acquired aplastic anaemia. A multivariate statistical analysis of 80 cases

1 reference

12 December 2020

Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum

1 reference

12 December 2020

Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia

1 reference

12 December 2020

Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia

1 reference

12 December 2020

Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro

1 reference

12 December 2020

Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia

1 reference

12 December 2020

Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party

1 reference

12 December 2020

High inducibility of heat shock protein 72 (hsp72) in peripheral blood mononuclear cells of aplastic anaemia patients: a reliable marker of immune-mediated aplastic anaemia responsive to cyclosporine therapy

1 reference

12 December 2020

Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes

1 reference

12 December 2020

Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil

1 reference

12 December 2020

Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia

1 reference

12 December 2020

10.1111/J.1365-2141.2008.07450.X

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference